LH
Labcorp Holdings, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$320.71
−0.63%Year over year
Reported trailing growth
- Revenue
- +6.4%
- EBITDA
- +15.0%
- EBIT
- +35.8%
- EPS
- +33.2%
- Free cash flow
- -8.4%
- Operating cash flow
- -3.3%
Forward estimates
Based on analyst estimates
- Revenue
- +5.1%
- EBITDA
- +30.4%
- EPS
- +55.6%
Three-year CAGR
- Revenue
- +5.6%
- EBITDA
- +1.0%
- EBIT
- +1.8%
- Net income
- -11.8%
- EPS
- -9.1%
- Free cash flow
- -6.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026